These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2650320)

  • 1. Cytoimmunologic monitoring for the diagnosis of acute rejection after heart transplantation.
    Wijngaard PL; van der Meulen A; Schuurman HJ; Gmelig Meyling FH; Heyn A; Borleffs JC; Jambroes G
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2521-2. PubMed ID: 2650320
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytoimmunologic monitoring as an adjunct in monitoring rejection after heart transplantation: results of a 6-year follow-up in heart transplant recipients.
    Wijngaard PL; Doornewaard H; van der Meulen A; Plomp S; Gmelig Meyling FH; de Jonge N; Schuurman HJ
    J Heart Lung Transplant; 1994; 13(5):869-75. PubMed ID: 7803429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytoimmunological monitoring to detect rejection after heart transplantation.
    Jutte NH; Daane R; van den Bemd JM; Hop WC; Essed CE; Simoons ML; Bos E; Weimar W
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2519-20. PubMed ID: 2650319
    [No Abstract]   [Full Text] [Related]  

  • 4. Reproducibility and reliability of cytoimmunological monitoring (CIM) of heart transplanted patients (HTP).
    Klanke D; Hammer C; Schübel C; Caca C; Dirschedl P; Gokel M; Kemkes BM
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2512-3. PubMed ID: 2650316
    [No Abstract]   [Full Text] [Related]  

  • 5. Cytoimmunologic monitoring and heart transplantation.
    Hanson CA; Bolling SF; Stoolman LM; Schlegelmilch JA; Abrams GD; Miska PT; Deeb GM
    J Heart Transplant; 1988; 7(6):424-9. PubMed ID: 3062148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytoimmunologic monitoring (CIM) for differentiation between cardiac rejection and viral, bacterial, or fungal infection: its specificity and sensitivity.
    Hammer C; Klanke D; Lersch C; Dirschedl P; Kemkes BM; Gokel M; Reichenspurner H; Reichart B
    Transplant Proc; 1989 Aug; 21(4):3631-3. PubMed ID: 2669269
    [No Abstract]   [Full Text] [Related]  

  • 7. Cytoimmunologic monitoring in early and late acute cardiac rejection.
    Fieguth HG; Haverich A; Schäfers HJ; Wahlers T; Herrmann G; Frimpong-Boateng K; Cremer J; Kemnitz J; Borst HG
    J Heart Transplant; 1988; 7(2):95-101. PubMed ID: 3284990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Additive value of immunologic monitoring to histologic grading of heart allograft biopsy specimens: implications for therapy.
    Fisher PE; Suciu-Foca N; Ho E; Michler RE; Rose EA; Mancini D
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1156-61. PubMed ID: 8719463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunologic-cytologic monitoring of heart transplant patients].
    Hammer C
    Z Kardiol; 1986; 75 Suppl 5():121-3. PubMed ID: 3548117
    [No Abstract]   [Full Text] [Related]  

  • 10. Correlation of interleukin-2 receptor positive circulating lymphocytes and acute cardiac rejection.
    Fieguth HG; Haverich A; Hadam M; Kemnitz J; Dammenhayn L
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2517-8. PubMed ID: 2650318
    [No Abstract]   [Full Text] [Related]  

  • 11. Cytoimmunologic monitoring after heart transplantation.
    Reichenspurner H; Hammer C
    J Heart Lung Transplant; 1994; 13(5):876. PubMed ID: 7803430
    [No Abstract]   [Full Text] [Related]  

  • 12. Cyto-immunologic monitoring following heart transplantation.
    Wijngaard PL; Heyn A; van der Meulen A; de Vries H
    Bibl Cardiol; 1988; (43):137-41. PubMed ID: 3067713
    [No Abstract]   [Full Text] [Related]  

  • 13. Monitoring of cardiac transplants with beta 2-microglobulin, cytoimmunological monitoring and endmyocardial biopsy: what's their value in detecting rejection?
    Semik M; Konertz W; Westphal E; Heusermann U; Friedl A; Bernhard A
    Bibl Cardiol; 1988; (43):133-6. PubMed ID: 3067712
    [No Abstract]   [Full Text] [Related]  

  • 14. Sustained elevated concentrations of cardiac troponin T during acute allograft rejection after heart transplantation in children.
    Wåhlander H; Kjellström C; Holmgren D
    Transplantation; 2002 Oct; 74(8):1130-5. PubMed ID: 12438959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive patient control after heart transplantation. A 6-year experience at the Munich University Hospital.
    Kemkes BM; Angermann C; Haberl R; Reichenspurner H; Klanke D; Anthuber M; Gokel M
    Bibl Cardiol; 1988; (43):119-27. PubMed ID: 3067710
    [No Abstract]   [Full Text] [Related]  

  • 16. Xenogeneic and allogeneic canine heart transplantation: a model for cytologic and immunologic monitoring of rejection mechanisms.
    Reichenspurner H; Ertel W; Reichart B; Peters D; Welz A; Uberfuhr P; Kemkes BM; Gokel JM; Hammer C
    J Heart Transplant; 1986; 5(6):471-6. PubMed ID: 3302180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelin plasma levels in acute graft rejection after heart transplantation.
    Dengler TJ; Zimmermann R; Tiefenbacher CP; Braun K; Sack FU; Kübler W
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1057-64. PubMed ID: 8719451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunologic-cytologic monitoring following heart transplantation].
    Lersch C; Hammer C; Klanke D; Reichenspurner H; Kemkes BM
    Fortschr Med; 1988 Sep; 106(27):541-3. PubMed ID: 3053374
    [No Abstract]   [Full Text] [Related]  

  • 19. Diagnosis of acute cardiac rejection by changes in left ventricular volumes.
    Novitzky D; Cooper DK; Boniaszczuk J; Rose AG
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2533. PubMed ID: 2650325
    [No Abstract]   [Full Text] [Related]  

  • 20. Neopterin as a new marker to detect acute rejection after heart transplantation.
    Havel M; Laczkovics A; Teufelsbauer H; Müller MM; Wolner E
    J Heart Transplant; 1989; 8(2):167-70. PubMed ID: 2651621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.